Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial

Authors

Institutions

Publication Details

Journal
Nephrology Dialysis Transplantation
Published
2025-07-04
DOI
https://doi.org/10.1093/ndt/gfaf119
Citations
6
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
7.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial

Max Miller, Maria Leonsson‐Zachrisson, Nicolás Guzmán, Hiddo J.L. Heerspink et al.
6 citations
Nephrology Dialysis Transplantation
Diabetes Treatment and Management
7.77
article

Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial

Max Miller, Maria Leonsson‐Zachrisson, Nicolás Guzmán, Hiddo J.L. Heerspink, Patrick Barry Mark, Anna L. Eriksson, Erika De Sousa‐Amorim, Yunyun Jiang
article en
6 citations

Abstract

No abstract available for this paper.
Nephrology Dialysis TransplantationVol. 40(12)
University Medical Center Groningen (NL), AstraZeneca (Poland) (PL), AstraZeneca (Spain) (ES), Queen Elizabeth University Hospital (GB), University of Glasgow (GB)
AstraZeneca
Good health and well-being
Openalex Percentile: Top 2%
Diabetes Treatment and Management
7.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.